Compare APT & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | APT | INMB |
|---|---|---|
| Founded | 1983 | 2015 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.4M | 44.1M |
| IPO Year | 1995 | 2019 |
| Metric | APT | INMB |
|---|---|---|
| Price | $4.50 | $1.54 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $4.30 |
| AVG Volume (30 Days) | 23.0K | ★ 493.6K |
| Earning Date | 11-05-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.34 | N/A |
| Revenue | ★ $59,096,000.00 | $50,000.00 |
| Revenue This Year | N/A | $264.29 |
| Revenue Next Year | N/A | $14,337.26 |
| P/E Ratio | $13.09 | ★ N/A |
| Revenue Growth | N/A | ★ 19.05 |
| 52 Week Low | $4.06 | $1.38 |
| 52 Week High | $6.20 | $11.64 |
| Indicator | APT | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 53.22 | 37.01 |
| Support Level | $4.34 | $1.75 |
| Resistance Level | $4.51 | $1.90 |
| Average True Range (ATR) | 0.10 | 0.12 |
| MACD | 0.00 | -0.05 |
| Stochastic Oscillator | 81.48 | 0.76 |
Alpha Pro Tech Ltd is in the business of protecting people, products and environments. It is developing, manufacturing and marketing a line of disposable protective apparel and infection control products for the cleanroom, industrial, pharmaceutical, medical and dental markets. It also manufacture a line of building supply construction weatherization products that are sold under the Alpha Pro Tech brand name. The Company operates through two business segments: Building Supply and Disposable Protective Apparel. Key revenue is generated from Building Supply: consisting of a line of construction supply weatherization products. The construction supply weatherization products consist of housewrap and synthetic roof underlayment and synthetic roof underlayment accessories.
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.